Seres Therapeutics Inc (MCRB)
0.798
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 14:37
Seres Therapeutics Total Liabilities (Quarterly): 408.80M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 408.80M |
| March 31, 2024 | 401.00M |
| December 31, 2023 | 403.46M |
| September 30, 2023 | 382.82M |
| June 30, 2023 | 383.77M |
| March 31, 2023 | 318.06M |
| December 31, 2022 | 338.00M |
| September 30, 2022 | 244.28M |
| June 30, 2022 | 250.14M |
| March 31, 2022 | 238.93M |
| December 31, 2021 | 223.35M |
| September 30, 2021 | 220.56M |
| June 30, 2021 | 168.58M |
| March 31, 2021 | 161.99M |
| December 31, 2020 | 168.19M |
| September 30, 2020 | 168.15M |
| June 30, 2020 | 166.25M |
| March 31, 2020 | 172.27M |
| December 31, 2019 | 180.76M |
| September 30, 2019 | 156.37M |
| Date | Value |
|---|---|
| June 30, 2019 | 164.06M |
| March 31, 2019 | 176.88M |
| December 31, 2018 | 168.52M |
| September 30, 2018 | 139.61M |
| June 30, 2018 | 146.21M |
| March 31, 2018 | 149.40M |
| December 31, 2017 | 128.82M |
| September 30, 2017 | 126.37M |
| June 30, 2017 | 128.41M |
| March 31, 2017 | 133.40M |
| December 31, 2016 | 140.02M |
| September 30, 2016 | 143.52M |
| June 30, 2016 | 138.82M |
| March 31, 2016 | 134.64M |
| December 31, 2015 | 11.51M |
| September 30, 2015 | 4.846M |
| June 30, 2015 | 6.368M |
| March 31, 2015 | 4.451M |
| December 31, 2014 | 144.07M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
161.99M
Minimum
Mar 2021
408.80M
Maximum
Jun 2024
263.13M
Average
238.93M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Chimerix Inc | 22.93M |
| Cellectar Biosciences Inc | 17.00M |
| Marinus Pharmaceuticals Inc | 134.43M |
| Jaguar Health Inc | 44.88M |
| PDS Biotechnology Corp | 29.58M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 321.73M |
| Shareholders Equity (Quarterly) | -87.07M |